Last reviewed · How we verify
NCT05869214: MEA-WCVD
Middle East African Registry Women CardioVascular Disease
trial in Heart Failure in 2,000 participants. Status unknown.
10 July 2023
Quick facts
| Lead sponsor | Tunisian Society of Cardiology and Cardiovascular Surgery |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 2,000 |
| Start date | 10 May 2023 |
| Primary completion | 10 July 2023 |
| Estimated completion | 10 July 2023 |
| Sites | 1 location across Tunisia |
Conditions studied
- Heart Failure — all drugs for Heart Failure →
- Atrial Fibrillation — all drugs for Atrial Fibrillation →
- Valvular Heart Disease — all drugs for Valvular Heart Disease →
- Ischemic Heart Disease — all drugs for Ischemic Heart Disease →
Sponsor
Tunisian Society of Cardiology and Cardiovascular Surgery
Who can join
18 and older, any sex, with Heart Failure or Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The MEA cardiology societies have joined forces to tackle the issue by establishing a tangible real-world data registry in every MEA country. This endeavor has resulted in the development of a multicenter registry called MEA-WCVD, which is being sponsored by each national cardiology society from participating countries. All data gathered will be consolidated into a singular registry for thorough analysis. Country specific analysis will be performed.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Cardiovascular disease in North African women: insights from the Middle East African Women CardioVascular Disease (MEA-WCVD) registry.
Charfeddine S, Abid L, Chenik S, Ben Krayen I, et al · · 2025 · PMID 40989112 · DOI 10.3389/fcvm.2025.1577793
Verify or expand the search:
- PubMed search for NCT05869214
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Heart Failure
Currently open trials in the same condition.
- NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
- NCT07496372 — Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart · Phase 3 · recruiting
- NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
- NCT07263035 — Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure · Phase 4 · recruiting
- NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05869214 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tunisian Society of Cardiology and Cardiovascular Surgery
- Last refreshed: 22 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05869214.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing